Ind-Swift Laboratories Ltd. Statistics
Want to see IN:INDSWFTLAB full AI Analyst Report?
Ind-Swift Laboratories Ltd. (INDSWFTLAB) Stock Statistics & Valuation Metrics
Total Valuation
Ind-Swift Laboratories Ltd. has a market cap or net worth of INR 31.50B. The enterprise value is INR 30.10B.
- Market Cap
- INR 31.50B
- Enterprise Value
- INR 30.10B
Share Statistics
Ind-Swift Laboratories Ltd. has 86,961,555 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 86,961,555
- Owned by Insiders
- ―
- Owned by Institutions
- 0.17%
Financial Efficiency
Ind-Swift Laboratories Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 0.86%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 0.86%
- Return on Capital Employed (ROCE)
- 0.01
- Revenue Per Employee
- 4.62M
- Profits Per Employee
- 298.38K
- Employee Count
- 1,388
- Asset Turnover
- 0.38
- Inventory Turnover
- 3.05
Valuation Ratios
The current PE Ratio of Ind-Swift Laboratories Ltd. is 36.92. Ind-Swift Laboratories Ltd.’s PEG ratio is -0.47.
- PE Ratio
- 36.92
- PS Ratio
- 4.16
- PB Ratio
- 2.13
- Price to FCF
- -66.26
- Price to Operating Cash Flow
- -154.75
- PEG Ratio
- -0.47
Income Statement
In the last 12 months, Ind-Swift Laboratories Ltd. had revenue of 6.41B and earned 414.15M in profits. Earnings per share was 4.95.
- Revenue
- 6.41B
- Gross Profit
- 1.90B
- Operating Income
- 144.91M
- Pretax Income
- 491.45M
- Net Income
- 414.15M
- EBITDA
- 450.97M
- Earnings Per Share (EPS)
- 4.95
Cash Flow
In the last 12 months, operating cash flow was -202.50M and capital expenditures -270.44M, giving a free cash flow of -472.94M billion.
- Operating Cash Flow
- -202.50M
- Free Cash Flow
- -472.94M
- Free Cash Flow per Share
- -5.44
Dividends & Yields
Ind-Swift Laboratories Ltd. pays an annual dividend of INR 1.00, resulting in a dividend yield of ―
- Dividend Per Share
- INR 1.00
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.51%
- Earnings Yield
- 2.67%
Stock Price Statistics
- Beta
- 0.52
- 52-Week Price Change
- 250.39%
- 50-Day Moving Average
- 373.28
- 200-Day Moving Average
- 228.19
- Relative Strength Index (RSI)
- 49.35
- Average Volume (3m)
- 61.63K
Important Dates
Ind-Swift Laboratories Ltd. upcoming earnings date is Feb 17, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 17, 2027
- Ex-Dividend Date
- Sep 20, 2011
Financial Position
Ind-Swift Laboratories Ltd. as a current ratio of 3.80, with Debt / Equity ratio of 1.48%
- Current Ratio
- 3.80
- Quick Ratio
- 3.22
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- -9.08
- Interest Coverage Ratio
- 10.31
Taxes
In the past 12 months, Ind-Swift Laboratories Ltd. has paid 77.30M in taxes.
- Income Tax
- 77.30M
- Effective Tax Rate
- 0.16
Enterprise Valuation
Ind-Swift Laboratories Ltd. EV to EBITDA ratio is 27.37, with an EV/FCF ratio of -59.51.
- EV to Sales
- 3.74
- EV to EBITDA
- 27.37
- EV to Free Cash Flow
- -59.51
- EV to Operating Cash Flow
- -139.00
Balance Sheet
Ind-Swift Laboratories Ltd. has INR 4.42B in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 4.42B billion.
- Cash & Marketable Securities
- INR 4.42B
- Total Debt
- INR 0.00
- Net Cash
- INR 4.42B
- Net Cash Per Share
- INR 50.80
- Tangible Book Value Per Share
- INR 159.38
Margins
Gross margin is 34.15%, with operating margin of 9.37%, and net profit margin of 11.10%.
- Gross Margin
- 34.15%
- Operating Margin
- 9.37%
- Pretax Margin
- 13.89%
- Net Profit Margin
- 11.10%
- EBITDA Margin
- 13.66%
- EBIT Margin
- 9.37%
Analyst Forecast
The average price target for Ind-Swift Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 66.39%
- EPS Growth Forecast
- -72.31%
Scores
- Smart Score
- ―
- AI Score
- 51
